The studies so far raise interesting questions about why some fusion proteins seem to be specific to a particular disease, such as TAZ::CAMTA1 to EHE, whereas others are more permissive across a range of tumors, such as YAP::MAML2 to poroma, metaplastic thymoma, and glioblastoma, among others. Here, CAMTA1 is linked to glioblastoma.